DSM-IV-TR vs. Proposed DSM-5: Comparison, Implications and Impact
NAADAC webinar free to all professionals.
This presentation will utilize diagnostic information on a sample of more than 7,000 adults from a structured interview that captures elements of both diagnostic formulations. We will examine the similarities and differences under the proposed DSM-5 for alcohol, cannabis, and cocaine diagnoses. For some groups, the new diagnoses will be place the same people into a comparable diagnostic group. However, for those with a current diagnosis of abuse, substantial changes in diagnoses will be noted. Clinical and policy implications will be discussed.
As a result of participating in this webinar, you will be able to:
- describe the proposed DSM-5 criteria and how it differs from the current DSM-IV-TR;
- explain why some with a current diagnosis of abuse will not receive a diagnosis with the new criteria;
- identify which diagnostic orphans (those with dependence indications but no diagnosis) will get a diagnosis in the new criteria;
- discuss the similarities and differences based on the substance under consideration;
- discuss the clinical and policy implications for DUI/DWI offenders.
Contact bbengtson@orionhealthcare.com for problems with registration.
